Hepion Pharmaceuticals(HEPA)
$0.120.00 (0.00%)
HEPA
Hepion Pharmaceuticals financials statements
$0.12
At close:0.00 (0.00%)
Hepion Pharmaceuticals (HEPA) Income Statement
790 Followers
Hepion Pharmaceuticals Income Statement
Last quarter (Q2 2026), Hepion Pharmaceuticals's total revenue was $0.00. In Q2, Hepion Pharmaceuticals's net income was $-1.25M. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 4.16M | $ 19.35M | $ 48.45M | $ 45.49M | $ 30.40M | |
| Depreciation and Amortization | $ 30.76K | $ 30.76K | $ 67.13K | $ 77.46K | $ 86.07K |
| $ -3.73M | $ -14.88M | $ -49.26M | $ -45.00M | $ -32.63M | |
| $ -4.16M | $ -19.35M | $ -48.45M | $ -45.49M | $ -30.40M | |
| $ -4.11M | $ 3.18M | $ -887.11K | $ 404.83K | $ -2.32M | |
| $ -8.28M | $ -16.16M | $ -49.34M | $ -45.08M | $ -32.72M | |
| $ -8.28M | $ -13.19M | $ -48.93M | $ -42.20M | $ -32.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.88 | $ -107.35 | $ -616.07 | $ -594.75 | $ -465.52 |
| Diluted EPS | $ -0.88 | $ -107.35 | $ -616.07 | $ -594.75 | $ -465.52 |
| Weighted Average Shares Outstanding | 9.41M | 122.89K | 79.42K | 76.23K | 70.29K |
| Weighted Average Shares Outstanding (Diluted) | 9.41M | 122.89K | 79.42K | 76.23K | 70.29K |
Currency in USD

